RLYB
RallybioDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RLYB vs peer average
48/100
RLYB vs. peer average (D vs. D)
Grade spread
A 1 · B 2 · D 1 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANTX is the first available peer comparator.
Small-cap clinical-stage biotech with comparable market cap and rare-disease/clinical development risk profile.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RLYB
Rallybio
ANTX
AN2 Therapeutics
Grade
D
A
Momentum
88
99
Value
41
41
Sentiment
0
54
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ANTX
RLYB / ANTX
Grade Position
In line
RLYB vs. peer average (D vs. D)
48/100
Momentum
88
ANTXValue
41
RLYBSentiment
0
ANTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RLYB
ANTX is the first peer returned for this comparison set.